# Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male Volunteers

> **NCT00800579** · PHASE1 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 12 (estimated)

## Conditions studied

- Cystic Fibrosis

## Interventions

- **DRUG:** GS-9411
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00800579
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2009-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00800579

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00800579, "Trial to Assess the Safety, Tolerability and Pharmacokinetics of GS-9411 in Healthy Male Volunteers". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00800579. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*